Invizyne Technologies Aims to Sell 4.3M Shrs at $4 Each in IPO
By Mary de Wet Biotechnology company Invizyne Technologies plans to sell 4.3 million shares at $4 each in an initial public offering. The company has a...
Stay updated with breaking news from Invizyne Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Mary de Wet Biotechnology company Invizyne Technologies plans to sell 4.3 million shares at $4 each in an initial public offering. The company has a...
Addison, TX, Jan. 31, 2024 -- MDB Capital Holdings, LLC, , a public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are...
Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a...
MDB Capital Holdings to Host Third Quarter 2023 Results Conference Call on November 15, 2023 at 4:30 PM Eastern Time
DENVER & HOUSTON--(BUSINESS WIRE)--Oct 17, 2023--